scholarly article | Q13442814 |
P356 | DOI | 10.1093/JNCI/84.18.1422 |
P8608 | Fatcat ID | release_orehfzocefhavniov5lds7dequ |
P698 | PubMed publication ID | 1512794 |
P5875 | ResearchGate publication ID | 21642516 |
P50 | author | Rochelle E Curtis | Q114398893 |
P2093 | author name string | Fraumeni JF Jr | |
Travis LB | |||
Hankey BF | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
lymphocyte | Q715347 | ||
P304 | page(s) | 1422-1427 | |
P577 | publication date | 1992-09-01 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Second cancers in patients with chronic lymphocytic leukemia. | |
P478 | volume | 84 |
Q33905245 | A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma |
Q61758368 | Adénocarcinome à cellules claires du rein et prolifération lymphomateuse de type B : une association fortuite? |
Q93901025 | An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients |
Q34744993 | Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses |
Q58045534 | B-cell lymphoma associated with chronic lymphatic leukaemia: two cases with contrasting aggressive and indolent behaviour |
Q37229036 | CD5 positive breast carcinoma in a patient with untreated chronic lymphocytic leukaemia: molecular studies of chromosome 13q |
Q71067681 | Chronic lymphocytic leukemia |
Q36057875 | Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options |
Q53394500 | Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry. |
Q30679241 | Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic |
Q36311279 | Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia |
Q39227230 | Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. |
Q36647851 | Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland |
Q36050986 | Eyelid carcinoma in patients with systemic lymphoma |
Q40291554 | Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma |
Q47218376 | Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers |
Q44089913 | Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia |
Q35194358 | Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. |
Q37406801 | Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies |
Q33706519 | High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression |
Q34390891 | Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion |
Q44741136 | Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature |
Q37471637 | Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion |
Q35626311 | Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma. |
Q51913809 | Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. |
Q40958079 | Hodgkin's disease: basing treatment decisions on prognostic factors |
Q44475819 | Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. |
Q77068387 | Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia |
Q61799313 | Immunochemotherapy for Richter syndrome: current insights |
Q36935200 | Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia |
Q39354550 | Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients |
Q35867744 | Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota |
Q41221077 | Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia |
Q46143500 | Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls |
Q48119206 | Leptomeningeal melanoma and Creutzfeldt-Jakob disease in a patient with chronic lymphocytic leukaemia |
Q89770415 | Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) |
Q78507151 | Lymphadenopathy detected by ultrasound examination as first diagnostic hint of chronic lymphocytic leukaemia in a patient with melanoma |
Q33873273 | Management of chronic lymphocytic leukaemia |
Q27320787 | Melanoma Risk and Survival among Organ Transplant Recipients. |
Q36512842 | Melanoma in immunosuppressed patients |
Q83969782 | Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report |
Q42476544 | Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia |
Q36141288 | Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers |
Q35146823 | Normalization of lymphocyte count after high ablative dose of I-131 in a patient with chronic lymphoid leukemia and secondary papillary carcinoma of the thyroid. Case report |
Q38228585 | Optimal management of skin cancer in immunosuppressed patients |
Q46852364 | Origin of high-grade lymphomas in Richter syndrome |
Q37163867 | Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma |
Q37879960 | Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study |
Q44404920 | Pulmonary complications in chronic lymphocytic leukemia |
Q42053064 | Recurrent Malignant Melanoma Presenting as Isolated Pleural Metastases in a Patient with Chronic Lymphocytic Leukemia. |
Q38263924 | Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy. |
Q36090959 | Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. |
Q37098627 | Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. |
Q91688305 | Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors |
Q38689777 | Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma |
Q51539401 | Risk of second cancer after lymphohematopoietic neoplasm. |
Q48378119 | Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy |
Q42438488 | Sebaceous carcinoma in the clinical setting of non-Hodgkin lymphoma: the Mayo Clinic experience |
Q35262838 | Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. |
Q97681519 | Second cancer incidence in CLL patients receiving BTK inhibitors |
Q35625192 | Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes |
Q42229190 | Second lung malignancy and Richter syndrome in chronic lymphocytic leukemia: case report and literature review |
Q36069481 | Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia |
Q34488720 | Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype |
Q36134555 | Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden |
Q34293457 | Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment |
Q34765318 | Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association? |
Q36814959 | Skin lesions in chronic lymphocytic leukemia |
Q76383189 | Squamous cell carcinoma of the uterine cervix in association with stage 0 chronic lymphocytic leukemia/small lymphocytic lymphoma |
Q37570768 | Synchronous or Metachronous Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: A Case Series and Literature Review |
Q41761884 | Synchronously diagnosed lymph nodal collision tumor of malignant melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: case report |
Q41519077 | The emergence of Hodgkin's disease in a patient with long-standing chronic lymphocytic leukemia--case report and review of the literature |
Q34201417 | The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology |
Q35153656 | Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia |
Q35192794 | Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine? |
Q90389794 | Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia |
Q35838726 | Two smalls in one: Coincident small cell carcinoma and small lymphocytic lymphoma in a lymph node diagnosed by fine-needle aspiration biopsy |
Q40540417 | Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine |
Search more.